Application of a validated prognostic plasma protein biomarker test for renal decline in type 2 diabetes to type 1 diabetes: the Fremantle Diabetes Study Phase II.

Autor: Davis, Timothy M. E., Davis, Wendy A., Bringans, Scott D., Lui, James K. C., Lumbantobing, Tasha S. C., Peters, Kirsten E., Lipscombe, Richard J.
Zdroj: Clinical Diabetes & Endocrinology; 10/10/2024, Vol. 10 Issue 1, p1-5, 5p
Databáze: Complementary Index